Abortion pill is the most common method to end a pregnancy in the U.S., CDC finds

Abortion pill is the most common method to end a pregnancy in the U.S., CDC finds


Boxes of the medication Mifepristone used to induce a medical abortion are prepared for patients at Planned Parenthood health center in Birmingham, Alabama, March 14, 2022.

Evelyn Hockstein | Reuters

The abortion pill is the most common method to terminate a pregnancy in the U.S., according to the Centers for Disease Control and Prevention.

The CDC, in a report published Wednesday, found that about 51% of abortions in 2020 were performed with the pill at or before the ninth week of pregnancy. From 2019 to 2020, abortions with the pill increased 22%, according to the report.

The pill, mifepristone, has become a flashpoint in the battle over reproductive rights in the wake of the Supreme Court’s decision to abolish federal abortion rights in June. Twelve states have outlawed abortion since then, but banning the pill is difficult because it has become easier to obtain.

In response to the Covid-19 pandemic, the Food and Drug Administration suspended a requirement that women obtain mifepristone in person, allowing them to receive the pill by mail and at retail pharmacies. The drug agency announced in December 2021 that it would make this change permanent.

Anti-abortion groups last week asked a federal court in Texas to overturn the FDA’s more than two-decade-old approval of mifepristone. The groups’ attorneys are from the Alliance Defending Freedom, an organization involved in the Dobbs v. Jackson Women’s Health Organization case that led the Supreme Court to overturn Roe v. Wade.

CNBC Health & Science

Read CNBC’s latest global health coverage:

Sen. Elizabeth Warren, D-Mass., and eight other senators asked the FDA in a letter last week to to expand access to mifepristone by approving its use for miscarriage management. This would improve women’s access to the pill in states that are restricting access, the senators wrote.

The FDA has approved mifepristone in combination with the tablet misoprostol as a method to terminate pregnancies before the 10th week. Mifepristone prevents the pregnancy from continuing and misoprostol causes contractions that empty the uterus. The method is 96% to 98% effective at ending early pregnancies.

The abortion pill has become an increasingly common way to end a pregnancy in the U.S. Abortions with the pill increased 154% from 2011 to 2020, according to CDC data.

More than 620,000 abortions were performed in the U.S. in 2020, a 15% decrease since 2011. Almost all abortions, 93%, are performed at or before the 13th week of pregnancy, and 80% are done at or before the ninth week, according to the CDC data.

Surgical abortions are the second most common method to end a pregnancy. About 40% of all abortions were performed with surgical procedures at or before that 13th week of pregnancy, according to the CDC.



Source

Healthy Returns: Amgen joins a growing list of drugmakers selling directly to consumers
Health

Healthy Returns: Amgen joins a growing list of drugmakers selling directly to consumers

The Amgen headquarters in Thousand Oaks, California. Eric Thayer | Bloomberg | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Drugmakers are increasingly using telehealth platforms to sell their medicines directly to patients […]

Read More
Laura Modi, CEO and mom, is breaking one of the market’s biggest duopolies: Infant formula
Health

Laura Modi, CEO and mom, is breaking one of the market’s biggest duopolies: Infant formula

Laura Modi, co-founder and CEO of infant formula startup Bobbie, is on a mission to transform an industry that she says has been stagnant for decades, and shift the culture around how parents feed their babies. Modi, a former Airbnb executive, came up with the idea for Bobbie after the birth of her first child. […]

Read More
Trump’s pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakers
Health

Trump’s pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakers

U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla (L) as he announces a deal with Pfizer to lower Medicaid drug prices in the Oval Office of the White House on September 30, 2025 in Washington, DC. Win Mcnamee | Getty Images President Donald Trump’s long-awaited threat to impose pharmaceutical tariffs may not […]

Read More